Abstract
The effects of three amphetamine analogs were assessed in pigeons key pecking under a multiple 3-min fixed-interval (FI), 30 response fixed-ratio (FR) schedule of food presentation. At doses between 0.1 and 10.0 mg/kg, (±) 3,4-methylenedioxyamphetamine (MDA), (±) 3,4-methylenedioxymethamphetamine (MDMA), and (±)-N-ethyl-3,4-methylenedioxyamphetamine (MDE) either had no effect or decreased response rates in both components of the multiple schedule in a dose-dependent manner. MDA was at least 1 log unit more potent than the other two compounds. Metergoline (0.1–1.0 mg/kg), a serotonin (5-HT) antagonist with comparable affinity for the 5-HT1 and 5-HT2 receptor subtypes, blocked the rate-decreasing effects of 3.0 mg/kg MDA in both components of the multiple schedule, but did not affect the MDMA dose-response curve. The 5-HT2 receptor antagonist ketanserin (0.1–3.0 mg/kg) also restored FI and FR responding that was decreased by 3.0 mg/kg MDA, but had no effect on responding suppressed by MDMA. The noradrenergic alpha-1 antagonist prazosin (0.3–3.0 mg/kg) blocked the behavioral effects of 3.0 mg/kg MDMA at doses that did not attenuate MDA's rate-decreasing effects. These results indicate that although MDA and MDMA are structurally similar and have similar behavioral effects, their actions appear to be mediated through different neurotransmitter systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson GM, Braun G, Braun U, Nichols DE, Shulgin AT (1978) Absolute configuration and psychomimetic activity. In: Barnett G, Trsic M, Willette RE (eds) Quasar: quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens. NIDA Res Monogr no 22, pp 8–15
Buckholtz NS, Freedman DX, Middaugh LD (1985) Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain. Eur J Pharmacol 109:421–425
Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338–345
Dews PB (1958) Studies on behavior. IV. Stimulant actions of methamphetamine. J Pharmacol Exp Ther 122:137–147
Dews PB, Wenger GR (1977) Rate-dependency of the behavioral effects of amphetamine. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology, vol 1. Academic Press, New York, pp 167–227
Ferster CR, Skinner BF (1957) Schedules of reinforcement. Appleton-Century-Crofts, New York
Gehlert DR, Schmidt CJ, Wu L, Lovenberg W (1985) Evidence for specific methylenedioxymethamphetamine (Ecstasy) binding sites in the rat brain. Eur J Pharmacol 119:135–136
Glennon RA (1979) The effects of chirality on serotonin receptor affinity. Life Sci 24:1487–1492
Glennon RA (1986) Discriminative stimulus properties of phenylisopropylamine derivatives. Drug Alcohol Depend 17:119–134
Glennon RA, Young R (1984a) MDA: An agent that produces stimulus effects similar to those of 3,4-DmA, LSD and cocaine. Eur J Pharmacol 99:249–250
Glennon RA, Young R (1984b) MDA: a psychoactive agent with dual stimulus effects. Life Sci 34:379–383
Glennon RA, Young R (1984c) Further investigation of the discriminative stimulus properties of MDA. Pharmacol Biochem Behav 20:501–505
Glennon RA, Young R, Rosecrans JA, Anderson GM (1982) Discriminative stimulus properties of MDA analogs. Biol Psychiatry 17:807–814
Glennon RA, Young R, Rosecrans JA (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol 91:189–196
Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505–2511
Glennon RA, Little PJ, Rosecrans JA, Yousif M (1987) The effect of MDMA (“Ecstasy”) and its optical isomers on schedule-controlled responding in mice. Pharmacol Biochem Behav 26:425–426
Gunn JA, Gurd MR, Sachs I (1939) The actions of some amines related to adrenaline: methoxyphenylisopropylamines. J Physiol 94:485–500
Lyon RA, Glennon RA, Titeler M (1986) 3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacology 88:525–526
Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW (1982) Effects of certain hallucinogenic amphetamine analogues on the release of [3H] serotonin from rat brain synaptosomes. J Med Chem 25:530–535
Peroutka SJ (1987) Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, “Ecstasy”) on an undergraduate campus. N Engl J Med 317:1542–1543
Rasmussen K, Aghajanian GK (1986) Effects of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists. Brain Res 385:395–400
Ricaurte G, Bryan L, Strauss L, Seiden L, Schuster C (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229:986–988
Rosecrans JA, Glennon RA (1987) The effect of MDA and MDMA (“Ecstasy”) isomers in combination with pirenpirone on operant responding in mice. Pharmacol Biochem Behav 28:39–42
Schmidt CJ (1987a) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1–7
Schmidt CJ (1987b) Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur J Pharmacol 136:81–88
Shulgin AT (1978) Psychotomimetic drugs: structure-activity relationships. In: Iverson LL, Iverson SD, Snyder SH (eds) Handbook of psychopharmacology, vol 11. Plenum Press, New York, pp 243–333
Silverman PB, Ho BT (1980) The discriminative stimulus properties of 2,5-dimethyoxy-4-methylamphetamine (DOM). Differentiation from amphetamine. Psychopharmacology 68:209–215
Simpson DL, Rumack BH (1981) Methylenedioxyamphetamine: clinical description of overdose, death, and review of pharmacology. Arch Int Med 141:1507–1509
Stone DM, Stahl DC, Hanson GR, Gibb JW (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41–48
Tessel RE, Barrett JE (1986) Antagonism of the behavioral effects of cocaine and d-amphetamine by prazosin. Psychopharmacology 90:436–440
Tilson HA, Sparber SB (1973) The effects of d-and l-amphetamine on fixed-interval and fixed-ratio behavior in tolerant and non-tolerant rats. J Pharmacol Exp Ther 187:372–379
Wetnink EA (1938) The effects of certain drugs and hormones upon conditioning. J Exp Psychol 22:150–163
Yamamoto BK, Spanos LJ (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148:195–203
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nader, M.A., Hoffmann, S.M. & Barrett, J.E. Behavioral effects of (±) 3,4-methylenedioxyamphetamine (MDA) and (±) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems. Psychopharmacology 98, 183–188 (1989). https://doi.org/10.1007/BF00444689
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00444689